Total baseline tumor size predicts survival among patients with advanced small-cell lung cancer receiving chemotherapy plus programmed death-ligand 1 inhibitor as first-line therapy: a multicenter retrospective observational study.

导出 LinkOut

翻译打印收藏纠错

作者： Anna,Tanaka ^[1] ; Shuhei,Teranishi ^[1] ; Yukihito,Kajita ^[1] ; Tomofumi,Hirose ^[1] ; Ayami,Kaneko ^[2] ; Yu,Sairenji ^[3] ; Hidetoshi,Kawashima ^[4] ; Kentaro,Yumoto ^[5] ; Toshinori,Tsukahara ^[6] ; Kenji,Miura ^[3] ; Nobuaki,Kobayashi ^[2] ; Masaki,Yamamoto ^[1] ; Ryuichi,Nishihira ^[4] ; Makoto,Kudo ^[1] ; Naoki,Miyazawa ^[7] ; Masanori,Nishikawa ^[8] ; Takeshi,Kaneko ^[2]

作者单位： Respiratory Disease Center, Yokohama City University Medical Center, Yokohama, Japan. ^[1] Department of Pulmonology, Yokohama City University Graduate School of Medicine, Yokohama, Japan. ^[2] Department of Respiratory Medicine, Yokohama Sakae Kyosai Hospital, Yokohama, Japan. ^[3] Department of Respiratory Medicine, Kanto Rosai Hospital, Kawasaki, Japan. ^[4] Department of Respiratory Medicine, Yokohama Minami Kyosai Hospital, Yokohama, Japan. ^[5] Department of Respiratory Medicine, Chigasaki Municipal Hospital, Chigasaki, Japan. ^[6] Department of Respiratory Medicine, Yokohama Nanbu Hospital, Yokohama, Japan. ^[7] Department of Respiratory Medicine, Fujisawa Municipal Hospital, Fujisawa, Japan. ^[8]

关键词 baseline tumor size first-line therapy immune checkpoint inhibitor overall survival programmed death-ligand 1 inhibitor small-cell lung cancer

DOI 10.3389/fonc.2024.1400277

PMID 39558947

发布时间 2024-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2024年14卷

1400277页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Total baseline tumor size predicts survival among patients with advanced small-cell lung cancer receiving chemotherapy plus programmed death-ligand 1 inhibitor as first-line therapy: a multicenter retrospective observational study.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Total baseline tumor size predicts survival among patients with advanced small-cell lung cancer receiving chemotherapy plus programmed death-ligand 1 inhibitor as first-line therapy: a multicenter retrospective observational study.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除